Topic: Orphan Drugs

Martin Shkreli appears on Tucker Carlson's show to defend his business model of acquiring "orphan drugs" and raising prices. Shkreli argues that his profits fund research for rare diseases and that the media unfairly targets him while ignoring price hikes by major firms like Pfizer.

The Orphan Drug Act is being exploited by companies like KV Pharmaceuticals to repatent old, cheap compounds and raise prices from $30 to $30,000. The FDA is criticized for allowing patent exclusivity on existing drugs and failing to protect the public from corporate monopolies.